Capital District Health Authority

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Fabry disease1 trial
• Stroke1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Completed2 trials

Lead sponsor

• Chiesi Farmaceutici S.p.A.1 trial
• Population Health Research Institute1 trial

Closed trials

• Completed

  Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

  NCT03566017· Phase 3· Chiesi Farmaceutici S.p.A.· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Population Health Research Institute· Source